dsm-firmenich reports 4% Q1 sales growth, launches €500M buyback, maintains 2026 outlook

dsm-firmenich posted a solid 4% like-for-like sales growth in Q1 2026, driven by strong volume in Perfumery & Beauty and steady performance across other units despite geopolitical challenges. The company launched a €500 million share buyback program aimed at capital reduction and announced a dual listing on the SIX Swiss Exchange starting May 21, 2026. It maintained its full-year 2026 outlook with expected 2-4% sales growth and around 20% adjusted EBITDA margin. Strategic focus remains on accelerating growth, improving margins, and managing costs amid global uncertainties.